Expert Speakers

Silvia Goldoni

Investigator & Head of Oncology Lab

Novartis

Sangeetha Palakurthi

Vice President

Elstar Therapeutics

Louise Cadzow

Senior Director, Head of In Vivo Pharmacology

KSQ Therapeutics

Mithun Khattar

Scientist & Immuno-oncology Lead

Takeda

Ethel Pereira

Research Scientist

Bristol-Myers Squibb

Rekha Pal

Director - Scientific Engagement

Crown Bioscience

Dr. Joshua Breunig

Assistant Professor

Sinai Medical Center

Dr. James Keck

Senior Director, Innovation & Product Development

The Jackson Laboratory

Courtney Anderson

Senior Scientist

AstraZeneca

Silvia Coma

Associate Director

Verastem Oncology

Sarah Knutson

Director of Preclinical Biology

Twenty Eight- Seven Therapeutics

Mohanraj Dhanabal

Scientific Fellow, Translational Research & Early Development

ikena Oncology

Kader Thiam

Vice President - Transgenic Technologies & Director - Business Development

GenOway

Kin-Hoe Chow

Associate Director

Patient Derived Models Center, Dana-Farber Cancer Institute

Jonathan Rios-Doria

Associate Director

Incyte

Aaron Goldman

Instructor in Medicine and Associate Bioengineer

Harvard Medical School

Jean Viallet

CEO

Inovotion

Jessica Freeling

Physiology Core Facility Director

The University of South Dakota

Keith Ligon

Director - Center For Patient Derived Models, Principal Investigator, Neuropathologist & Pathologist

Dana-Farber Cancer Institute

Dr Holger Weber

Head of In Vivo Pharmacology

ProQuinase

Chris Armstrong

CEO

Overwatch Research

Dr. Maryland Franklin

Executive Director - Scientific Development

Covance

Qingcong Lin

CEO

Biocytogen

Fallon Noto

Director In Vivo & Oncology Services

Hera BioLabs